The relationship between serum uric acid and chronic kidney disease among Appalachian adults

Loretta Cain1, Anoop Shankar, Alan M Ducatman

  • 1Department of Community Medicine, West Virginia University School of Medicine, Morgantown, WV 26506-9190, USA.

Insights

Higher serum uric acid (SUA) levels are linked to chronic kidney disease (CKD). This study found a significant positive association between elevated SUA and increased risk of developing CKD in adults.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Elevated serum uric acid (SUA) is linked to cardiovascular disease and hypertension, a CKD risk factor.
  • The independent association between SUA and chronic kidney disease (CKD) remains unclear.
  • This study investigated the hypothesis that higher SUA levels are positively associated with CKD.

Purpose of the Study:

  • To determine if serum uric acid (SUA) is independently associated with chronic kidney disease (CKD).
  • To quantify the association between different levels of SUA and the prevalence of CKD.

Main Methods:

  • Analysis of data from the C8 Health Study, a population-based cohort of 49,295 Appalachian adults.
  • Serum uric acid (SUA) levels were analyzed in gender-specific quartiles.
  • Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m².

Main Results:

  • A significant positive association was observed between increasing quartiles of SUA and CKD.
  • Compared to the lowest quartile, odds ratios for CKD in higher SUA quartiles were 1.53, 2.16, and 4.67.
  • This association remained significant and consistent in analyses stratified by gender.

Conclusions:

  • Higher serum uric acid (SUA) levels are independently associated with chronic kidney disease (CKD).
  • The findings suggest that CKD may mediate a portion of the association between SUA and cardiovascular disease.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...